Silver Book Fact

Researchers have found how to manipulate embryonic stem cells to form dopamine-producing brain cells. This new source of cells could someday be used to replace cells lost to Parkinson’s.

Perrier A, Tabar V, Barberi T, Rubio M, et al. Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells. Proceedings of the National Academy of Sciences. 2004; 101(34): 12543-8. http://www.pnas.org/cgi/content/short/101/34/12543

Reference

Title
Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells
Publication
Proceedings of the National Academy of Sciences
Publication Date
2004
Authors
Perrier A, Tabar V, Barberi T, Rubio M, et al.
Volume & Issue
Volume 101, Issue 34
Pages
12543-8
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Some studies have indicate that the management of high cholesterol, type 2 diabetes, high blood pressure, overweight or obesity, and other cardiovascular risk factors may help avoid or delay cognitive…  
  • According to the Pharmaceutical Research and Manufacturers of America, one of the most promising medicines in development uses normal human cells to enhance brain levels of dopamine, the neurotransmitter deficient…  
  • One study found that dopaminergenic therapies for Parkinson’s disease patients resulted in lower dyskinesias as well as lower incidences of freezing, drowsiness, and edema–resulting in better quality-of-life through symptom control.  
  • 91 medicines are currently in development for Alzheimer’s disease.  
  • An Alzheimer’s disease treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce Medicaid costs for people with the disease by $14 billion in 2020–from…